(Q40251060)

English

Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors

scientific article published on 15 April 2013

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit